Fibrinogen Tolaga Bay: A novel γAla341Val mutation causing hypofibrinogenaemia

Thrombosis and Haemostasis

Volumn 98, Issue 5, 2007, Pages 1136-1138

  Davis, Ryan L ^a   Brennan, Stephen O ^a,b  

^a UNIVERSITY OF OTAGO   (New Zealand)

^b CANTERBURY HEALTH LABORATORIES   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE DERIVATIVE; BRANCHED CHAIN AMINO ACID; FIBRINOGEN; VALINE;

ADULT; AMINO ACID SUBSTITUTION; ANAMNESIS; ARTICLE; CASE REPORT; COMPARATIVE STUDY; CONTROLLED STUDY; DNA SEQUENCE; ELECTROSPRAY MASS SPECTROMETRY; EXON; FEMALE; FIBRINOGEN BLOOD LEVEL; GENE LOCATION; GENE MUTATION; GENETIC CONSERVATION; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; HUMAN; HYPOFIBRINOGENEMIA; MUTATIONAL ANALYSIS; POINT MUTATION; POLYACRYLAMIDE GEL ELECTROPHORESIS; PREVALENCE; PRIORITY JOURNAL; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; RISK FACTOR; SEQUENCE ANALYSIS;

AFIBRINOGENEMIA; DNA MUTATIONAL ANALYSIS; FAMILY HEALTH; FEMALE; FIBRINOGENS, ABNORMAL; HETEROZYGOTE; HUMANS; MIDDLE AGED; MUTATION, MISSENSE; POINT MUTATION;

EID: 36048982912     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1160/TH07-05-0354     Document Type: Article

References (12)

1. Mosesson MW, Siebenlist KR, Meh DA. The structure and biological features of fibrinogen and fibrin. Ann NY Acad Sci 2001; 936: 11-30.
2. McKee PA, Rogers LA, Marler E et al. The subunit polypeptides of human fibrinogen. Arch Biochem Biophys 1966; 116: 271-279.
3. Kant JA, Fornace AJ, Jr., Saxe D et al. Evolution and organization of the fibrinogen locus on chromosome 4: gene duplication accompanied by transposition and inversion. Proc Natl Acad Sci USA 1985; 82: 2344-2348.
4. Huang S, Mulvihill ER, Farrell DH et al. Biosynthesis of human fibrinogen. Subunit interactions and potential intermediates in the assembly. J Biol Chem 1993; 268: 8919-8926.
5. Brennan SO. Electrospray ionisation analysis of human fibrinogen. Thromb Haemost 1997; 78: 1055-1058.
6. Brennan SO, Fellowes AP, Faed JM et al. Hypofibrinogenemia in an individual with 2 coding (gamma82 A->G and Bbeta235 P->L) and 2 noncoding mutations. Blood 2000; 95: 1709-1713.
7. Shimizu A, Nagel GM, Doolittle RF. Photoaffinity labeling of the primary fibrin polymerization site: isolation and characterization of a labeled cyanogen bromide fragment corresponding to gamma-chain residues 337-379. Proc Natl Acad Sci USA 1992; 89: 2888-2892.
8. Vu D, Di Sanza C, Caille D et al. Quality control of fibrinogen secretion in the molecular pathogenesis of congenital afibrinogenernia. Hum Mol Genet 2005; 14: 3271-3280.
9. Dear A, Dempfle CE, Brennan SO et al. Fibrinogen Mannheim II: a novel gamma307 His->Tyr substitution in the gammaD domain causes hypofibrinogenemia. J Thromb Haemost 2004; 2: 2194-2199.
10. Meyer M, Franke K, Richter W et al. New molecular defects in the gamma subdomain of fibrinogen D-domain in four cases of (hypo)dysfibrinogenemia: fibrinogen variants Hannover VI, Homburg VII Stuttgart and Suhl. Thromb Haemost 2003; 89: 637-646.
11. de Raucourt E, de Mazancourt P, Maghzal GJ et al. Fibrinogen Saint-Germain II: hypofibrinogenemia due to heterozygous gamma N345S mutation. Thromb Haemost 2005; 94: 965-968.
12. Song KS, Park NJ, Choi JR et al. Fibrinogen Seoul (FGG Ala341Asp): A Novel Mutation Associated With Hypodysfibrinogenemia. Clin Appl Thromb Hemost 2006; 12: 338-343.